Bionema expands global product portfolio

With growing public awareness and concerns about the effects of chemical pesticides on human health, biodiversity and the environment, there is greater demand for alternative solutions to control insect pests and enhance crop yields. Addressing these challenges, Bionema Ltd, a world-leading developer of biocontrol sustainable solutions, is introducing its range of more than 70 biological products for use in agriculture, horticulture, forestry, turf & amenities, and public health.

The BioAg market, which includes biopesticides, biostimulants and biofertilisers, has been estimated to be valued at USD 12.6 billion in 2022. It is projected to reach USD 24.6 billion by 2027, according to market analysts MarketsandMarkets, reflecting a CAGR of 13.6%. This rapid rate of growth reflects widespread and increasing demand for biological solutions as the world embraces more environmentally-friendly innovations.

Bionema’s new product catalogue lists more than 70 biopesticides, biostimulants, biofertilisers, molluscides, biocides, efficacy boosters, insect monitoring tools and nutrient management products. The portfolio expansion reflects Bionema’s evolution in focus and strategy, announced last year following the company’s deal with Syngenta that secured Bionema’s position as a world-leading biocontrol technology company.

Bionema’s management team set a new course to focus on company growth, which is has been implementing for the past 15 months and has resulted in an expanded product portfolio of products offering biological solutions for agriculture, horticulture, turf & amenities, forestry, and public health.

“Our vision to be a leading BioAg technology developer, reducing the need for chemical pesticides, has led us to where we are today,” said Dr Minshad Ansari, Founder and CEO of Bionema. “The world is changing and there is increased consumer, societal, regulatory and government demands for reduced chemical use – for example, consider the EU’s plan to remove 505 pesticides by 2030 and increase organic farming from 8 to 25%. Targets like this just won’t be feasible without sustainable alternatives, such as the ones we are launching now.”

Bionema’s expanded portfolio enhances the company’s offering to the BioAg sector, and complements its ongoing research, training and other services in the continuing development of novel biological solutions.

Bionema has collected a library of more than a thousand commercially-viable microorganisms for pipeline candidates, and the company’s innovative formulation and delivery technologies can lead to products that deliver higher virulence, greater stability, better spore yields, and wider host ranges.

“We are delighted to announce our new product catalogue now,“ added Dr Ansari. “But we also want to make it clear that we’re not done yet! We are continuing to work, to collaborate and to innovate. We have achieved a great amount, but we will never stop – we always think, the best is yet to come!”

For more information, visit www.bionema.com.

Source: